Curenetics utilizes an AI-powered platform that integrates genomics, imaging, and clinical data to predict individual patient responses to cancer therapies. This technology addresses the high variability in treatment effectiveness, enabling personalized treatment plans that improve patient outcomes and reduce unnecessary healthcare costs.
Funding
$4.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Cancer treatment effectiveness varies significantly among patients, leading to ineffective treatments, severe side effects, and high healthcare costs. Current prediction methods for immunotherapy response, such as PD-L1 and CPS scores, are often inaccurate, resulting in unexpected patient outcomes, relapse, and mortality.
Solution
Curenetics offers an AI-powered platform that integrates genomics, imaging, and clinical data to predict individual patient responses to cancer therapies. By analyzing multiple factors, including gene variations, medical history, and physical makeup, the platform enables personalized treatment plans. This approach aims to improve patient outcomes by identifying the most effective treatment options, reducing the likelihood of adverse side effects, and optimizing the use of healthcare resources. The AI-driven insights help patients and doctors make informed decisions about cancer treatment, increasing the certainty of positive impacts on patients' lives.
Target Audience
The primary target audience includes oncologists, cancer patients, and healthcare providers seeking to improve cancer treatment outcomes through personalized medicine.
Features
- AI-powered prediction of individual patient responses to cancer therapies
- Integration of genomics, imaging, and clinical data for comprehensive analysis
- Identification of gene variations, medical history, and physical makeup as factors influencing treatment response
- Personalized treatment plans based on predicted effectiveness
- Reduction of ineffective treatments and severe side effects
- Optimization of healthcare resource allocation